On day 1, GLP-1 was infused to stimulate endogenous insulin release and suppress endogenous glucagon. On days 2–5, pancreatic endocrine clamps were performed using somatostatin infusions of ...

Other specific hormones related to clinical syndromes are gastrin for Zollinger–Ellison syndrome, insulin/proinsulin for hypoglycemia symptoms, glucagon for glucagonomas and vasoactive ...

Supplemental BLA accepted for review Paltusotine (Crinetics Pharmaceuticals) Somatostatin receptor type ... types 1 and 2 inhibitor As an adjunct to insulin therapy for glycemic control in adults ...

Somatostatin receptor type 2 agonist Treatment and long-term maintenance of acromegaly in adults. NDA accepted for review Zynquista (Lexicon Pharmaceuticals) Dual sodium-glucose co-transporter types 1 ...

Glucagon is a hormone produced by α cells in the pancreas. It works alongside insulin to regulate blood sugar levels, raising them when they drop too low. However, in people with type 2 diabetes ...

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

It also caps insulin costs at $35 per month for Medicare beneficiaries and a $2,000 out-of-pocket annual cap for people enrolled in a certain drug plan. Trump's reversal of the 2022 "Lowering ...

Minnesota Attorney General Keith Ellison on Monday announced a settlement in a lawsuit against insulin manufacturer Novo Nordisk. Minnesota residents will now be able to get Novo Nordisk insulin ...

A thorough examination of modern drugs that target particular receptors and metabolic pathways for glucose and fat metabolism is presented. Recent research has revealed innovative targets and ...

Many drugs, including insulin, essentially became free. But the American Rescue Plan made a major change that hit drug companies with even larger penalties for raising prices. In January 2024 ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two ...